As part of our ongoing interest in the potential offered by
natural products to act as leads in the development of new antituberculosis
20 and antimalarial agents,10,21 we now report the
synthesis of pseudopyronines A and B, the preparation of
a number of analogues and the results of screening these compounds
for activity against whole organisms and purified
recombinant enzymes of the FAB pathway.